title: Photodynamic therapy: a light in the darkness?
abstract: Photodynamic therapy (PDT) is used to treat localized premalignant or early malignant disease. This study reports the enhanced, systemic antitumor immune response from PDT, suggesting that it may have a potential role as a therapy to address both local and disseminated disease.
authors.affiliation: University of Pennsylvania, Department of Radiation Oncology, Philadelphia, Pennsylvania, USA. lina@xrt.upenn.edu
authors.forename: Alexander
authors.initials: A
authors.lastname: Lin
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Hahn
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004353:Drug Evaluation, Preclinical; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D008954:Models, Biological; D010778:Photochemotherapy / Q000639:trends*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D019496:Cancer Vaccines